chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Has them now, was given 2nd shot twice/ Suspected vaccination failure; Has them now, was given 2nd shot twice; 2nd shot given twice; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 3rd dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and extra dose administered. On an unknown date, the outcome of the vaccination failure, shingles and extra dose administered were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 16-FEB-2023 Reporter's comment: This case was reported by a patient via interactive digital media. The reporters husband had them now and reporter believe because patient received 2nd shot twice. The reporter reported that they did not read the records and gave it to patient. The reporter was furious not sure how she going to handle this. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The patient had received the 2nd dose of Shingrix twice, which led to extra dose administered. The follow-up could not be possible as no contact details were available.
Had two episodes of chest pain on 31 Mar 03 at about 1815.  Pt called the Clinic.  Saw a provider on 1 Apr. No follow up treatment advised.
had covid; had covid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 94-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 94 years for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing); "Hypothyroid" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID taken for hypothyroidism; PRAVASTINE taken for blood cholesterol increased; SERTRALINE taken for anxiety. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "had covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: (May2022) Positive.  Clinical course: It was reported that after further discussion with reporter's 40-year-old daughter, her mom was no longer frightened. Reporter's daughter told her she had very similar sleep/dream disturbances after dose 4. They feel the problem was a side effect due to 4 dose and having had covid in May2022. They feel it was just the way her mom is 94-year old body reacted and that there was nothing wrong with the serum, as the same thing happened with her daughter who is 54-years younger and had her dose 4 in a clinic setting.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
103 fever, violent shaking, extreme nausea, body ache, headache. Lasted 3 days
rt arm hot, swollen, hard;unable to move arm @ all;11/8/99 movement improved 9entire upper arm), erythema;11/9/99 erythema edema moved to lower rt arm;movement improved;
Bood pressure raised; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (Bood pressure raised) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 046B21A) for COVID-19 vaccination.     Concurrent medical conditions included Thalassemia minor. Concomitant products included LOSARTAN for Blood pressure high, ATENOLOL for Hypertension.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (Bood pressure raised). At the time of the report, HYPERTENSION (Bood pressure raised) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. Caller stated that  blood pressure raised, is an unusual thing to happen to the caller.   This case was linked to MOD-2021-347546 (Patient Link).
Within 8 hours of second vaccine I began having symptoms of autoimmune reactivity years under control. It started with hives and oral angioedema I was able to quell with some on hand steroids and high does Benadryl - I am an ARNP . This went on for a few weeks until a critical time on 2/19/2021 when a full flare was uncontrollable affecting my airway I was not able to stop the ongoing immunity as it built up over the 2 weeks.  My temporary measures could not keep it at bay. I was emergently taken to ER trauma bay and aggressively treated with Epi  0.3 IM x 2 high dose solumedrol x 3  125 mg and 60 mg IV and 50 mg Benadryl IV X3  Pepcid IV X1 then admitted to telemetry for severity overnight
Friday 1-8-21 Nausea began, intensified for a couple of hours - first vomiting began at 9:45 p.m.  2nd at 11:30 p.m. Saturday 1-9-21 Nausea continued.  Could not keep food down.  First vomiting at 9 a.m. - 6 times total finishing at 10:11 p.m.  Saturday night.  Chills started at 4:15 p.m.  Continuing on and off to present 1/10/2021 at 4:34 p.m.  Insomnia - 1-2 hours of fitful sleep each day. Left arm bicep soreness morning of 1-7-21.  Aleve resolved.  Less than shingles vaccine.
Chicken pox lesions on face, arms, neck, following varicella vaccination 2 wks earlier.
extremely low blood pressure 74/50 within an hour of vaccination.  Light headed and dizzy.  Fainted once.  Blood pressure remained low thru the next day 74/50 in the AM climbing back to 117/61 by 1am.
Breakthrough COVID infection. Tested due to fever on 08/07/2022. Test collected 08/07/2022 and positive.
fatigue for a day with the first 2 doses; arm soreness for a couple of days with the first 2 doses; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue for a day with the first 2 doses) and VACCINATION SITE PAIN (arm soreness for a couple of days with the first 2 doses) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 007M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue for a day with the first 2 doses) and VACCINATION SITE PAIN (arm soreness for a couple of days with the first 2 doses). At the time of the report, FATIGUE (fatigue for a day with the first 2 doses) and VACCINATION SITE PAIN (arm soreness for a couple of days with the first 2 doses) had resolved.            No treatment information provided by the reporter  It was reported that  patient had no comorbidities, no regular chronic medications.  Patient received third dose of Moderna on 08-Nov-2021, Batch number: 039F21A.   This case was linked to MOD-2021-384309, MOD-2021-384344 (Patient Link).
Patient reported redness at site and going down arm from site, went to ER the next day and was given iv fluids, her GP gave her antibiotics indicating a possible infection the next day 10/12/12 and she is still recovering.
Vision Loss; other zoster-related conditions; other zoster-related conditions; This spontaneous report was received from a lawyer regarding a case in litigation and refers refers to a currently 76-year-old patient (pt) of unknown gender. The pt's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date in 2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (exact dose, site and route of administration, lot# and expiration date were not provided) in a pharmacy by a pharmacist for the long-term prevention of shingles and zoster-related conditions. Subsequently, the pt was treated for the following injuries resulting from the pt's zoster vaccine live (ZOSTAVAX) use: vision loss and other zoster-related conditions. The outcome of the events was unknown. The causality assessment between the events and zoster vaccine live (ZOSTAVAX) was related.  Upon internal review, the event of vision loss was determined to be medically significant.
I had lightheaded, dizzy, blurred vision, and fainting. I went to urgent care.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On or about 15-JUN-2015, the patient was inoculated with ZOSTAVAX at a clinic for routine adult health maintenance and for the prevention of shingles (route, dose, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 16-JUN-2016, the patient was treated at the same clinic for the onset of a severe vesicular rash, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was considered related. Additional information has been requested.
Patient received 2nd dose of Pfizer Vaccination and stated she was having difficulty swallowing/throat closing. Pt stated they had TMJ. Pt was given water to swallow and felt of after sitting on bed for 45 min. Last vitals showed slight improvement to blood pressure. Pt was released at 1615. Original symptoms were resolved.
No medical history was provided by the reporter.     On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PYREXIA (fever), FATIGUE (feels fatigued) and CHILLS (chills). On 07-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). On 15-Mar-2021, the patient experienced HEADACHE (On and off headache). At the time of the report, PAIN IN EXTREMITY (Sore arm), HEADACHE (On and off headache) and FATIGUE (feels fatigued) had not resolved and PYREXIA (fever), CHILLS (chills), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  Treatment information was not provided.
Episode of heart  pounding; Felt dizzy; Her Menstrual cycle went off track; This is a spontaneous report received from Pfizer sponsored program COVAX US Support from a contactable consumer reported for her daughter. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as UNKNOWN, SINGLE for covid-19 immunisation.  The patient's medical history and concomitant medications were not reported.  The reporter stated her Daughter got pfizer covax series and 2.5 months later had an episode of heart pounding and felt dizzy. She also had her menstrual cycle went off track and she was always on time. She had not seen her HCP because she stated they moved and she needed to get one. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Possible allergic reaction 6" plate sized rash on back. Started 7 days later after vaccine. Skin is tender at rash, headache.
passed away days later; This is a spontaneous report from a Pfizer-sponsored program.  A female patient of an unspecified age received bnt162b2 (BNT162B2 also reported as Pfizer Covid-19 vaccines, lot unknown), via an unspecified route of administration on an unspecified date at dose unknown, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. She took the Pfizer Covid-19 vaccine and passed away days later (unspecified date). It was not reported if an autopsy was performed.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow-up.; Reported Cause(s) of Death: passed away days later
humming in both ears and ear pressure/stuffiness.  feels as though my ears are clogged
Caregiver expressed that patient developed tachycardia, slurred speech, and unable to get BP about 1 1/2 hrs after vaccine was administered.
Hives, difficulty breathing & pruritus which infant was rubbing the back of his head, nose, ears & eyes. pt was flushed w/PR 132. No wheezing noted. At inject site rt arm area was red edematous skin eruptions. Resolved in 4 days.
I have a pervious bunion my middle finger on my right hand, which became inflamed. I had to go to the ER to get medicated.
This case was reported by a physician via call center representative and described the occurrence of tachycardia in a elderly female patient who received Influenza vaccine Quadrivalent. Concurrent medical conditions included iodine allergy. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified at an unknown dose. On an unknown date, less than an hour after receiving Influenza vaccine Quadrivalent, the patient experienced tachycardia, tingling tongue and swollen tongue. On an unknown date, the outcome of the tachycardia, tingling tongue and swollen tongue were recovered/resolved. It was unknown if the reporter considered the tachycardia, tingling tongue and swollen tongue to be related to Influenza vaccine Quadrivalent. Additional details were provided as follows: The age at vaccination was not reported. The patient did not have an egg allergy. The patient received the influenza vaccine 4 to 5 years before the date of reporting (the healthcare professional was unsure which brand) and in less than 5 minutes after receiving vaccination, the patient experienced a reaction of tachycardia and tongue felt unusual (tingly and swollen). The events resolved within 5 minutes. The patient did not have any breathing or swallowing difficulty. The patient did not receive the flu vaccine since then.
states had covid vaccine #1 on 1/22/21, developed localized red rash on 1/25/21 at the injection site, is a little less red today, however, is noticing some bumps now and is slightly itchy , will use claritin
MODERNA 2ND DOSE VACCINATION AT AGE OT 17 TO COMPLETE THE SERIES (PATIENT RECEIVED MODERNA FOR THE 1ST DOSE ON 08/17/21. VAERS ALREADY SUBMITTED PREVIOUSLY FOR THE FIRST DOSE)
pt recv vax 18AUG95 & 11NOV97 pt devel chickenpox consisting of 16 lesions face, chest, & trunk;
Localized redness, swelling, hot to touch at (R) Deltoid inj. site, measured approx 2" x 3" when eval. @ HD on 1/17/13. Pt c/o of BP elevation. BP readings 150/100 (R) & (L). Pt reports her first Flu inj. Flu Mist 2 yrs ago. No reaction. Pt thinks she may be allergic to "preservatives" & when counseled says she has no hx of allergy to Thimersol or contact lens solutions.
pt recvd vax approx 10AM & devel reddness & edema; affected thigh has circ of 26.5 cm; nl thigh is 25.5cm;
1-2hr post vax nausea, chills, h/a, body aches often has rxn to meds;t98 & BP 120/80, pulse 78, resp 18;not short of breath, alert oriented;
THE NIGHT OF VACCINATION PATIENT GOT FEVER 99.9 F AND MORE THAN 24 HOURS PATIENT GOT RASH . AND AFTER 48 HOURS ALLL PROBLEM RESOLVED
Single patch of shingles in C5 distribution 9 days after administration of Zostavax
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022; Patient received vaccine past its 30-days expiry date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022) and EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30-days expiry date) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2022 at 4:00 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 30-Mar-2022 at 4:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30-days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022). At the time of the report, PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 30-Mar-2022) and EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30-days expiry date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by reporter. No treatment medications were provided by reporter.  On 30-Mar-2022 at 16:00:31, patient received an expired booster dose.  It was reported that vaccines went into 2-8 C thaw state on or above 24-Dec-2021 and were administered up until the MFG expiry date of 04-Apr-2022.  Prescriptions, over the counter medications, dietary supplements or herbal remedies being taken at time of vaccination or at the time of the adverse event were reported as unknown.  Other vaccines given on the same day as Moderna COVID-19 vaccine and other vaccines received within one month prior to any dose of Moderna COVID-19 vaccine were reported as unknown.   This case was linked to MOD-2022-542869.
some really weird side effects; left arm hurt; feeling awful; left arm swollen; joint pain/ left knee is hurting; Nausea; headaches; Fatigues; Chills; This spontaneous case was reported by a nurse and describes the occurrence of ADVERSE EVENT (some really weird side effects), PAIN IN EXTREMITY (left arm hurt), FEELING ABNORMAL (feeling awful), PERIPHERAL SWELLING (left arm swollen) and ARTHRALGIA (joint pain/ left knee is hurting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (some really weird side effects), PAIN IN EXTREMITY (left arm hurt), FEELING ABNORMAL (feeling awful), PERIPHERAL SWELLING (left arm swollen), ARTHRALGIA (joint pain/ left knee is hurting), NAUSEA (Nausea), HEADACHE (headaches), FATIGUE (Fatigues) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and PROMETHAZINE at an unspecified dose and frequency. At the time of the report, ADVERSE EVENT (some really weird side effects), PAIN IN EXTREMITY (left arm hurt), FEELING ABNORMAL (feeling awful), PERIPHERAL SWELLING (left arm swollen), ARTHRALGIA (joint pain/ left knee is hurting), NAUSEA (Nausea), HEADACHE (headaches), FATIGUE (Fatigues) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was reported
Blood clots; This is a spontaneous report from a non-contactable consumer through a Pfizer sales representative. An 80-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) as a single dose, with route of administration and therapy date unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had blood clots. The patient was hospitalized on an unspecified date due to the reported event. The outcome of the event, blood clot, was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Body aches / Crying in so much pain/body pain,; Chills; Fever; Vomiting; Confusion; Nausea; Little to no food intake; Eyes were swollen; crying in so much pain; Got 2 shots same day; Bad headache; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a female patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   Co-suspect products included Men B NVS (Meningococcal B vaccine) for prophylaxis.   On 31st July 2020, the patient received the 1st dose of Meningococcal B vaccine and Meningococcal B vaccine. On 31st July 2020, less than a day after receiving Meningococcal B vaccine and Meningococcal B vaccine, the patient experienced headache and overdose. On 1st August 2020, the patient experienced general body pain, chills, fever, vomiting, confusion, nausea, decreased appetite, eye swelling and crying. On an unknown date, the outcome of the headache, general body pain, chills, fever, vomiting, confusion, nausea, decreased appetite, eye swelling and crying were not recovered/not resolved and the outcome of the overdose was unknown.   It was unknown if the reporter considered the headache, general body pain, chills, fever, vomiting, confusion, nausea, decreased appetite, eye swelling and crying to be related to Meningococcal B vaccine and Meningococcal B vaccine.  Additional details were provided as follows: The case was reported by the parent of the patient. The age at vaccination was not reported. The patient received Meningococcal B vaccine and had bad reaction to the vaccine.  Severe headaches, vomiting, nausea, body pain, confusion and eyes were swollen.  The doctor said just a reaction and should resolve in 3 days and had been in tears. The patient had body aches, chills, fever, vomiting, confusion.  The patient got 2 shots same day, which led to overdose.  The reporter took her to emergency room because she was crying in so much pain.  The reporter just gave her something for nausea and sent her home.  The patient was on day 3 of same symptoms and little to no food intake.
leg weakness, ambulation impacted-required her husband to help her get to the bathroom d/t extreme weakness in her legs for 2 days, heart racing, feeling unwell